Although investors may question why the CEO left Zimmer Biomet for the 3M spinoff, which is similar in size, “it seems as though Mr. Hanson was nearing the end of his time in what he wanted to accomplish at [Zimmer Biomet],” Zimmerman said. Tornos, who has been COO since 2021, is expected to build on Hanson's legacy.